In Brief: Conceptus Inc.
This article was originally published in The Gray Sheet
Executive Summary
Conceptus Inc.: Receives 510(k) clearance for its transcervical fallopian tube catheterization system. The system, consisting of microcatheters and guidewires based on Target Therapeutics' neurovascular microcatheter technology, is designed to "enable physicians to enter the fallopian tubes through the cervix in order to more accurately and directly diagnose tubal disorders," the company says...